In support of our results, So et. al. [42] reported that an analogue of vitamin D3 (BXL0124) represses the expression of the stem cell marker CD44 in vitro and also decreased tumor growth of a xenograft in vivo [42]. The gene discussed is CD44; the disease is neoplasm.